IP Library › Assignment 022431/0053
Patent Assignment
Reel/Frame 022431/0053

Change of Name

Recorded: 2009-03-20 Pages: 4
Assignor
ESSENTIA BIOSYSTEMS, INC.
Executed: 2005-04-19
Assignee
REVANCE THERAPEUTICS, INC.
7555 GATEWAY BOULEVARD, NEWARK, CALIFORNIA, 94560
Covered Properties (11)
Cosmetic Formulations Containing L-Arginine Oligomers
Compositions and Methods for Topical Application and Transdermal Delivery of Botulinum Toxins
Multi-Component Biological Transport Systems
Patent: 7,807,780 →
Application: 09/910,432 →
Publication: US 2003/0229034
Cosmetic formulations containing l-arginine oligomers
Application: 10/505,299 →
Publication: US 2005/0226821
Modulation of Zinc Levels to Improve Tissue Properties
Patent: 8,975,295 →
Application: 10/692,191 →
Publication: US 2004/0157921
Compositions and Methods for Topical Diagnostic and Therapeutic Transport
Patent: 8,092,788 →
Application: 11/073,307 →
Publication: US 2005/0239705
Multi-component therapeutic transport systems
Application: 60/220,244 →
Cosmetic compositions containing L-arginine oligomers
Application: 60/358,879 →
Modulation of zinc levels to improve tissue properties
Application: 60/421,336 →
Compositions and methods for topical application and transdermal delivery of botulinum toxins
Application: 60/658,434 →
Compositions and methods for topical application and transdermal delivery of an oligopeptide
Application: 60/658,741 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 14, 2002
From: WAUGH, JACOB; DAKE, MICHAEL
To: ESSENTIA BIOSYSTEMS, INC.
Reel/Frame 012492/0919 →
Assignment of Assignor's Interest Mar 7, 2003
From: CIFRA, PAMELA; DAKE, MICHAEL D.; ELKINS, CHRISTOPHER; WAUGH, JACOB M
To: ESSENTIA BIOSYSTEMS, INC.
Reel/Frame 013472/0589 →
Assignment of Assignor's Interest Mar 2, 2004
From: CIFRA, PAMELA; DAKE, MICHAEL D.; ELKINS, CHRISTOPHER; WAUGH, JACOB M.
To: ESSENTIA BIOSYSTEMS, INC.
Reel/Frame 014391/0286 →
Assignment of Assignor's Interest Jul 6, 2005
From: DAKE, MICHAEL D.; WAUGH, JACOB M.
To: ESSENTIA BIOSYTEMS, INC.
Reel/Frame 016755/0031 →
Assignment of Assignor's Interest Jul 8, 2005
From: WAUGH, JACOB M.; DAKE, MICHAEL D.; ELKINS, CHRISTOPHER J.; CIFRA, PAMELA N.
To: ESSENTIA BIOSYSTEMS, INC.
Reel/Frame 016763/0532 →
Assignment of Assignor's Interest Jul 26, 2005
From: DAKE, MICHAEL D.; WAUGH, JACOB M.
To: ESSENTIA BIOSYSTEMS, INC.
Reel/Frame 016806/0045 →
Security Agreement May 29, 2009
From: REVANCE THERAPEUTICS, INC.
To: LEADER VENTURES, LLC
Reel/Frame 022756/0549 →
Security Agreement Sep 22, 2011
From: REVANCE THERAPEUTICS, INC.
To: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
Reel/Frame 026953/0726 →
Release of Security Interest Recorded at Reel/Frame 24432/321, 24432/284, 24432/317, 22432/187, and 22756/549 Oct 4, 2011
From: LEADER VENTURES, LLC
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 027015/0658 →
Security Agreement May 18, 2012
From: PRECISION DERMATOLOGY, INC.; ONSET DERMATOLOGICS, LLC; PROSKIN LLC; PRECISION MD LLC
To: MIDCAP FUNDING III, LLC
Reel/Frame 028234/0424 →
Assignment of Assignor's Interest Sep 28, 2012
From: REVANCE THERAPEUTICS, INC.
To: PRECISION DERMATOLOGY, INC.
Reel/Frame 029043/0761 →
Security Agreement Sep 20, 2013
From: PRECISION DERMATOLOGY, INC.
To: GCI CAPITAL MARKETS LLC
Reel/Frame 031249/0011 →
Release of Security Interest Sep 27, 2013
From: MIDCAP FUNDING III, LLC
To: PRECISION DERMATOLOGY COMPANY, INC.; ONSET DERMATOLOGICS, LLC; PROSKIN, LLC; PRECISION MD, LLC
Reel/Frame 031296/0492 →
Release of Security Interest Jul 7, 2014
From: GCI CAPITAL MARKETS, LLC
To: PRECISION DERMATOLOGY, INC.
Reel/Frame 033280/0556 →
Security Agreement Jul 6, 2015
From: ECR PHARMACEUTICALS CO., INC.; PRECISION DERMATOLOGY, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 036091/0257 →
Security Interest Jul 19, 2017
From: PRECISION DERMATOLOGY, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043041/0864 →
Security Interest Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Security Interest Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Release of Security Interest Sep 27, 2019
From: HERCULES CAPITAL, INC. (F/K/A HERCULES TECHNOLOGY GROWTH CAPITAL, INC.)
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 050565/0300 →
Security Interest Mar 18, 2022
From: REVANCE THERAPEUTICS, INC.
To: ATHYRIUM BUFFALO LP
Reel/Frame 059437/0654 →
Security Interest Feb 7, 2025
From: REVANCE THERAPEUTICS, INC.; CROWN LABORATORIES, INC.
To: HAYFIN SERVICES LLP, AS ADMINISTRATIVE AGENT
Reel/Frame 070153/0663 →
Security Interest Feb 7, 2025
From: REVANCE THERAPEUTICS, INC.; BELLUS MEDICAL, LLC; CROWN LABORATORIES, INC.
To: HAYFIN SERVICES LLP, AS ADMINISTRATIVE AGENT
Reel/Frame 070153/0736 →
Release of Security Interest Feb 7, 2025
From: ATHYRIUM BUFFALO LP
To: REVANCE THERAPEUTICS, INC
Reel/Frame 070153/0630 →
Security Interest Feb 17, 2025
From: REVANCE THERAPEUTICS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 070239/0739 →
Release of Security Interest Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →